Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish ...

Three life-science prizes were awarded for advances in gene therapies. Opthalmologists Jean Bennett and Albert Maguire, and ...

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

Molecular biologist Jean Bennett and ophthalmologist Albert Maguire will share the $3 million (£2.2m) "Breakthrough prize" ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Ultragenyx (NASDAQ:RARE) is one of the 10 Overlooked Growth Stocks to Buy Now.

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

Scientists discover salamander genes that help regrow limbs, using gene therapy to restore digit growth in mice.

The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

Investigating a common gene in three very different species—salamanders, mice and zebrafish—scientists have discovered the ...

The treatment for primary immunodeficient diseases is varied. As mentioned before, the most common type of primary immunodeficient disease are antibody deficiencies. Either patients don't make enough ...